Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angong Niuhuang Pill
- Development stage
- Phase 3
- Lead developer
- Huqing Yutang
- Modality
- Small Molecules
- Administration
- Oral, Nasogastric
01
Overview
Angong Niuhuang Pill is a traditional Chinese patent medicine with a history dating back to the Qing Dynasty, first described in the medical text "Treatise on Differentiation and Treatment of Epidemic Febrile Diseases" by Wu Jutong. It consists of 11 medicinal ingredients including Bovis Calculus, Powdered Buffalo Horn Extract, Artificial Moschus, Margarita, Cinnabaris, Realgar, Coptidis Rhizoma, Scutellariae Radix, Gardeniae Fructus, Curcumae Radix, and Borneolum Syntheticum. The formula is known for its antipyretic, anti-inflammatory, anticonvulsant, sedative, and neuroprotective properties. Modern pharmacological research has demonstrated its efficacy in treating various central nervous system conditions including stroke, coma, viral encephalitis, and traumatic brain injury. It has been shown to reduce cerebral infarct and edema volumes, improve neurological function, and promote recovery in comatose patients.
- Brand names
- Angong Niuhuang Wan
- Other names
- Angong Niuhuang Wan
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)FOXO3 (Forkhead box protein O3)HIF1A (Hypoxia-inducible factor 1-alpha)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)PIK3CA (Phosphoinositide 3-kinase alpha)FoxO signaling pathway
Beyond the preview
Go deeper on Angong Niuhuang Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angong Niuhuang Pill.